ClinicalTrials.Veeva

Menu

The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

M

Ministry of Health, Malaysia

Status

Unknown

Conditions

Carcinoma,Hepatocellular
Hepatitis B,Chronic

Study type

Observational

Funder types

Other

Identifiers

NCT01310062
09-317-3991

Details and patient eligibility

About

More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.

Enrollment

1,600 estimated patients

Sex

All

Ages

21+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients of at least 21 years old on day of giving consent for study
  • Patients must be able and wiling to give an informed consent
  • Patient with chronic HBV infection
  • Patient with active hepatocellular carcinoma and chronic hepatitis B
  • Healthy subjects

Exclusion criteria

  • Patients who have co-infection with HIV or chronic hepatitis C
  • Subjects with other types of cancer

Trial contacts and locations

8

Loading...

Central trial contact

Clinical Research Centre

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems